RCM acquisitions carry hidden compliance, concentration, and technology risks that derail deals. Know what to look for before you sign.
Find Vetted Medical Billing Company DealsMedical billing companies offer stable recurring revenue and recession-resistant demand, making them attractive acquisition targets. However, buyers who skip specialty-specific due diligence on HIPAA compliance, client concentration, and technology infrastructure routinely overpay or inherit serious liabilities.
Market Size
Approximately $15–20 billion in the U.S. outsourced medical billing and RCM market, with the broader RCM market exceeding $250 billion when including in-house operations
Growth Trend
Growing
Recession Resistant
Yes
Market Structure
Highly fragmented
Buyers often mistake gross billing volume for collectible recurring revenue. Without analyzing net collection rates and contract renewal terms by client, reported revenue figures significantly overstate what the business actually delivers.
How to avoid: Request 36 months of bank deposits, client-level revenue breakdowns, and all executed contracts showing fee structures, renewal dates, and termination clauses before accepting any revenue figure.
Many lower middle market billing companies derive 40–60% of revenue from one or two large practices. If those clients leave post-acquisition, the business value collapses rapidly regardless of purchase price paid.
How to avoid: Require a full client concentration analysis. Flag any single client exceeding 20% of revenue and negotiate an earnout tying a portion of the purchase price to that client's 24-month retention.
Buyers routinely close deals without verifying signed Business Associate Agreements with all clients and vendors, security risk assessments, or prior audit history. Inherited violations carry six-figure OIG penalties.
How to avoid: Engage a healthcare compliance attorney to audit all BAAs, review the HIPAA security risk assessment, and confirm no open CMS audits or payer recoupment demands exist before close.
In many RCM businesses, the selling owner personally manages all client relationships and handles escalated billing issues. Without a transition plan, clients follow the seller out the door post-close.
How to avoid: Insist on a 12–24 month transition agreement, structured client introductions pre-close, and document which staff can independently manage each account without owner involvement.
Legacy billing software with no active vendor support or modern EHR integration creates immediate post-close capital expenditure. Buyers fail to budget for migration costs that can reach $100K–$300K.
How to avoid: Inventory every software license, EHR integration agreement, and cybersecurity tool. Get independent IT assessment of migration cost and timeline before finalizing your purchase price.
Buyers accept seller claims of strong performance without independently validating denial rates and net collection rates by specialty. Declining metrics signal operational deterioration or worsening payer relationships.
How to avoid: Request 24 months of collection rate data segmented by payer and specialty. Compare against industry benchmarks—95%+ net collection rate is the standard for a healthy RCM operation.
Buyers submit SBA loan applications before independently verifying the Medical Billing Company's normalized EBITDA. When diligence reveals add-backs that don't hold, the deal's debt service coverage collapses and the loan fails underwriting.
How to avoid: Build your EBITDA model with conservative add-back assumptions before engaging an SBA lender. At current rates, a $1M SBA 7(a) loan costs approximately $13,000/month — the Medical Billing Company needs $195,000+ in post-salary EBITDA to clear 1.25x DSCR.
Buyers close on a Medical Billing Company assuming operations transfer smoothly, then discover undocumented processes, informal vendor relationships, and staff who rely on institutional knowledge the seller carries in their head.
How to avoid: Require a 60-day operational documentation period before closing. Walk through every key process with the seller present, document staff responsibilities, vendor contacts, and customer communication protocols. Build a 90-day integration plan before the wire hits.
What experienced buyers verify before committing to a Medical Billing Company acquisition.
The specific concerns and miscalculations buyers face in this industry.
Common miscalculations sellers make that reduce their final price or derail a deal.
Expect 3.5x–6x EBITDA depending on client diversification, contract quality, compliance history, and technology infrastructure. Businesses with 95%+ net collection rates and diversified specialty clients command the upper range.
Yes. Medical billing companies are SBA-eligible service businesses. Most deals are structured with SBA 7(a) financing covering 80–90% of the purchase price paired with a seller note covering the remaining balance.
Negotiate an earnout tying 15–25% of purchase price to client retention over 12–24 months. Require the seller to formally introduce you to all key clients before closing and sign a non-solicitation agreement.
Prioritize HIPAA BAA completeness, security risk assessment documentation, and any open payer audits or CMS recoupment demands. Undisclosed compliance violations can generate six-figure penalties that transfer to the buyer.
More Medical Billing Company Guides
DealFlow OS helps you find and evaluate acquisitions with seller signals and due diligence tools. Free to join.
Start finding deals — freeNo credit card required
For Buyers
For Sellers